Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...
TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...
Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 MonthsAccelerated pathway: ...
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene therapies.
Texas A&M AgriLife faculty, staff and graduate students earn Vice Chancellor’s Awards in Excellence honors at Texas A&M ...
LX2020 generally well tolerated across ten participants with no clinically significant complement activation LX2020 transduction, transcription, ...
ElevateBio Life Edit (R) is the Company's gene editing technologies and R&D business, focused on building the world's largest gene editing toolbox to expand addressable diseases and open a new ...
Cybersecurity has evolved from a technical discipline to a board-level business imperative. It determines enterprise ...
Google Cloud’s lead engineer for databases discusses the challenges of integrating databases and LLMs, the tools needed to ...
First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment ...
New Platform Empowers Automakers to Shift Software Engineering Focus from Infrastructure to Innovation LAS VEGAS, NEVADA / ACCESS Newswire / January 6, 2026 / QNX, a division of BlackBerry Limited (NY ...
While in the mid-2010s the country’s nominal gross domestic product stood at approximately USD 60-65 billion, it has now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback